ePrints

Amantadine-induced myoclonus in a patient with progressive supranuclear palsy

Lookup NU author(s): Professor Alison Yarnall, Professor David BurnORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Progressive supranuclear palsy (PSP) is a tauopathy that generally results in a hypokinetic disorder. Treatment is largely symptomatic, with some small studies indicating a benefit with dopaminergic therapy. Myoclonus is a hyperkinetic disorder that can be seen as part of later stage Parkinson's disease and in multiple system atrophy, but is rarely seen in PSP. Here we report a case of myoclonus precipitated by amantadine in a patient with PSP.

Publication metadata

Author(s): Yarnall AJ, Burn DJ

Publication type: Article

Publication status: Published

Journal: Age and Ageing

Year: 2012

Volume: 41

Issue: 5

Pages: 695-696

Print publication date: 15/03/2012

ISSN (print): 0002-0729

ISSN (electronic): 1468-2834

Publisher: Oxford University Press

URL: http://dx.doi.org/10.1093/ageing/afs043

DOI: 10.1093/ageing/afs043

Altmetrics

Share